Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 4.0B | 4.4B | 4.2B | 4.2B |
Cost of revenue | 1.3B | 1.5B | 1.5B | 1.3B |
Gross profit | 2.8B | 2.9B | 2.8B | 2.9B |
Operating expense | ||||
Research & development | 66.8M | 112.9M | 39.9M | 51.6M |
Selling general and admin | — | — | — | — |
Other operating expenses | 880.5M | 883.2M | 812.6M | 889.1M |
Operating income | 828.8M | 984.3M | 930.4M | 944.7M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 29.5M | 21.7M | 33.3M | 33.4M |
Other income expense | — | — | — | — |
Pretax income | 1.2B | 1.2B | 1.1B | 1.2B |
Tax provision | 298.6M | 310.2M | 280.0M | 305.3M |
Net income | 930.8M | 918.3M | 852.3M | 874.5M |
Basic EPS | 9.2 | — | 8.5 | 9.0 |
Diluted EPS | 9.2 | — | 8.5 | 9.0 |
Basic average shares | 101.3M | — | 100.5M | 97.1M |
Diluted average shares | 101.5M | — | 100.5M | 97.1M |
EBITDA | 1.5B | 1.5B | 1.4B | 1.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | — | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |